Eastman Chemical Files DEF 14A Proxy for 2025 Period

Def 14a - Eastman Chemical Co (0000915389) (Filer) Filing Summary
FieldDetail
CompanyDef 14a - Eastman Chemical Co (0000915389) (Filer)
Filed DateMar 24, 2026
Risk Levellow
Pages14
Reading Time17 min
Key Dollar Amounts$1 b, $500 million, $60 million, $1 billion, $100 million
Sentimentneutral

Complexity: moderate

Sentiment: neutral

Topics: proxy-statement, corporate-governance, annual-meeting, executive-compensation

TL;DR

**Eastman Chemical just dropped its proxy statement, get ready for the annual meeting details!**

AI Summary

EASTMAN CHEMICAL CO (0000915389) filed a DEF 14A proxy statement on March 24, 2026, for the period ending December 31, 2025. This filing, identified by SEC Accession No. 0000915389-26-000074, outlines important information for shareholders, likely including proposals for the upcoming annual meeting, executive compensation details, and board member elections. For investors, this matters because it provides crucial insights into the company's governance, strategic direction, and how management and the board are compensated, all of which can influence future stock performance and shareholder value.

Why It Matters

This filing is essential for shareholders to understand the company's governance, executive pay, and proposals that will be voted on, directly impacting their ownership rights and potential returns.

Risk Assessment

Risk Level: low — A DEF 14A filing is a standard regulatory disclosure and does not inherently present a direct financial risk, but rather provides information for investors to assess company-specific risks.

Analyst Insight

An investor should review the full DEF 14A document to understand the proposals for the upcoming annual meeting, executive compensation, and board structure, as these details can influence long-term investment decisions for EASTMAN CHEMICAL CO.

Key Numbers

  • 2026-03-24 — Filing Date (The date the DEF 14A was officially submitted to the SEC.)
  • 2025-12-31 — Period of Report (The fiscal period this proxy statement primarily covers, indicating the financial year for which governance and compensation details are being reported.)
  • 155 — Number of Documents (The total number of individual documents included in this specific SEC filing, suggesting a comprehensive disclosure.)
  • 2381897 — Size of Main Document (The size in bytes of the primary DEF 14A iXBRL document (emn-20260324.htm), indicating the volume of detailed information provided.)

Key Players & Entities

  • EASTMAN CHEMICAL CO (company) — the filer of the DEF 14A
  • 0000915389 (company) — the CIK of EASTMAN CHEMICAL CO
  • 0000915389-26-000074 (dollar_amount) — the SEC Accession No. for the filing
  • 2026-03-24 (date) — the filing date
  • 2025-12-31 (date) — the period of report

Forward-Looking Statements

  • EASTMAN CHEMICAL CO will hold its annual shareholder meeting shortly after the filing date of March 24, 2026, based on the DEF 14A proxy statement. (EASTMAN CHEMICAL CO) — high confidence, target: 2026-05-31
  • The DEF 14A will contain proposals for shareholder votes, including director elections and executive compensation approvals. (EASTMAN CHEMICAL CO) — high confidence, target: 2026-03-24

FAQ

What type of SEC filing is this document?

This document is a DEF 14A, which stands for 'Other definitive proxy statements,' as indicated by the 'Form: DEF 14A' and 'Description: DEF 14A emn-20260324.htm iXBRL DEF 14A' in the filing details.

When was this DEF 14A filing submitted to the SEC?

The filing date for this DEF 14A was March 24, 2026, and it was accepted on the same day at 16:03:50, according to the 'Filing Date' and 'Accepted' fields.

Which company filed this DEF 14A?

EASTMAN CHEMICAL CO, with CIK 0000915389, is the filer of this DEF 14A, as stated in the title and 'Filer' information.

What is the period of report covered by this filing?

The period of report for this DEF 14A is December 31, 2025, as specified under 'Period of Report 2025-12-31'.

How many documents are included in this specific SEC accession number?

There are 155 documents included in this filing, as indicated by 'Documents 155' in the filing detail.

Filing Stats: 4,343 words · 17 min read · ~14 pages · Grade level 14.2 · Accepted 2026-03-24 16:03:50

Key Financial Figures

  • $1 b — nerated operating cash flow approaching $1 billion, a clear validation of our discip
  • $500 million — ar. In total, we returned approximately $500 million through dividends and share repurchases
  • $60 million — versus 2024 and delivered approximately $60 million of incremental earnings. Continued Saf
  • $1 billion — nerated operating cash flow approaching $1 billion. Exceeded cost reduction goals, with a
  • $100 million — ive actions that achieved approximately $100 million in savings versus our target of greater
  • $75 million — vings versus our target of greater than $75 million. Achieved Kingsport methanolysis facil
  • $8.8 Billion — mbers Delaware (1993) Incorporated $8.8 Billion Total 2025 revenue NYSE (EMN) Publi
  • $8.8B — nes towards our sustainability goals. $8.8B Sales $776M Earnings before interest
  • $776M — r sustainability goals. $8.8B Sales $776M Earnings before interest and taxes ("E
  • $930M — ngs before interest and taxes ("EBIT") $930M Adjusted EBIT* $474M Net earnings
  • $474M — taxes ("EBIT") $930M Adjusted EBIT* $474M Net earnings $4.10 Diluted earnings
  • $4.10 — Adjusted EBIT* $474M Net earnings $4.10 Diluted earnings per share $5.42 Adj
  • $5.42 — gs $4.10 Diluted earnings per share $5.42 Adjusted diluted earnings per share*
  • $970M — Adjusted diluted earnings per share* $970M Net cash provided by operating activit
  • $500M — ovided by operating activities Approx. $500M Returned to stockholders (through divi

Filing Documents

Executive Compensation

Executive Compensation 49 Compensation Discussion and Analysis 49 Compensation Tables 68 Pay Ratio 77 Pay Versus Performance 78 ITEM 4 Approval of the 2026 Omnibus Stock Compensation Plan 82 ITEM 5 Advisory Vote on Stockholder Proposal Regarding Lowering the Threshold for Calling Special Shareholder Meetings to 10% 90 Information About Stock Ownership 93 Stock Ownership of Directors and Executive Officers 93 Principal Stockholders 95 Additional Information About the Annual Meeting 96 Annex A 101 A nnex B 118 Reconciliation of Non-GAAP Financial Measures 118 Frequently Requested Information About Eastman 8 2025 Performance Highlights 10 Director Nominees 21 Corporate Governance 27 Director Compensation 39

Executive Compensation

Executive Compensation 49 Information About Stock Ownership 93 2026 Proxy Statement 5 Table of contents Note about forward-looking statements Certain statements made in this proxy statement are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act (Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended (the "Exchange Act")), including statements relating to our executive compensation programs; expectations, strategies, and plans for businesses and for the whole of Eastman; capital allocation; future financial results; environmental matters and opportunities (including potential risks associated with physical impacts of climate change and related voluntary and regulatory carbon requirements); and our sustainability objectives and plans, including our engagement efforts. In some cases, you can identify forward-looking statements by terminology such as "anticipates", "believes", "estimates", "expects", "intends", "may", "plans", "projects", "forecasts", "will", "would", "could", and similar expressions or expressions of the negative of these terms. Forward-looking statements are based upon certain underlying assumptions as of the date such statements were made. Such assumptions are based upon internal estimates and other analyses of current market conditions and trends, management expectations, plans, and strategies, economic conditions, and other factors. Forward-looking statements and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. The known material factors, risks, and uncertainties that could cause actual results to differ materially from those in the f

View Full Filing

View this filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.